Brightening Ingredients Ranked: Niacinamide vs 377 vs Tranexamic Acid

How Do Brightening Ingredients Differ by Melanin Pathway?

Brightening ingredients split into three groups by where they act on the melanin process. Niacinamide and 377 work at different ends of the production line: 377 inhibits tyrosinase at the source, while niacinamide blocks the transfer of melanosomes into keratinocytes. Tranexamic acid works upstream by cutting the inflammation signal that activates melanocytes in the first place. Glabridin works across several of these points and adds antioxidant and soothing effects.

The pathway determines the claim, the loading range, and the formulation risk. A brand that wants to fade existing spots needs a different active than a brand that wants to prevent darkening after inflammation. A brand with a cost target needs to know which of the four carries the highest formulation burden rather than the highest raw material price.

One regulatory fact frames the whole category. In China, brightening products claiming spot fading and whitening fall under special cosmetics registration, while niacinamide at cosmetic levels can support a brightening claim as an ordinary cosmetic. That single distinction decides which of the four actives a China-bound product can carry.

Why Does Niacinamide Work at 2% to 5% but Fail Above 10%?

Niacinamide works in the 2% to 5% range and stops improving above 10%, where it starts causing redness and stinging instead. It delivers the widest formulation window of the four because it is water soluble, cheap, and stable in ordinary processes.

Niacinamide does not kill melanin. After melanocytes synthesize melanin in the basal layer, the pigment travels through dendrites to epidermal keratinocytes, and niacinamide blocks that transfer, with reported inhibition rates of 35% to 68%. It also accelerates the shedding of melanin-containing keratinocytes and adds barrier support and oil control.

A double-blind study found that 5% niacinamide used for 12 weeks reduced the area of facial hyperpigmentation spots by 21.4% and improved overall skin tone evenness. Industry consensus places the effective and tolerable range at 2% to 5%.

The concentration trap is real and it is a raw material quality issue as much as a dose issue. Impurities left over from manufacturing, particularly nicotinic acid, drive the redness and stinging that appear at high loading. A brand buying a 5% formula from one supplier and a 12% formula from another may see worse tolerance in the higher-loading product.

The commercial limits are also clear. Niacinamide works poorly on spots already deposited deep in the epidermis, and the raw material is mature enough that it cannot differentiate a product on its own.

What Makes 377 the Hardest Brightening Ingredient to Formulate?

377 is the hardest of the four to formulate because it barely dissolves in water and oxidizes under light and heat, so it needs encapsulation, an antioxidant system, and controlled emulsification to survive. It also sits under a 0.5% regulatory ceiling in China, which means the efficacy has to come from formulation quality rather than from more active.

Phenylethyl resorcinol, known as 377, is a synthesized potent brightening agent whose structure resembles resveratrol. It inhibits tyrosinase directly, and reported inhibition is 22 times that of kojic acid and 49 times that of arbutin.

A clinical test on Asian subjects found that 12 weeks of a formulation containing 0.5%, the maximum permitted addition under Chinese regulation, reduced spot area by 28% and raised the skin tone L-value by 14%.

The formulation burden is what separates capable manufacturers. 377 turns yellow or brown under light and high temperature, so the supplier needs encapsulation technology, an antioxidant system, and an emulsification process that holds the active without heat damage. It also carries some irritation potential, so sensitive-skin products need a tolerance panel.

When Does Tranexamic Acid Beat Every Other Brightening Active?

Tranexamic acid beats the others when the target concern is melasma or post-inflammatory hyperpigmentation, because it treats the inflammation signal rather than the pigment itself.

Tranexamic acid was originally an anticoagulant drug, and its brightening effect was found as a side effect in clinical practice. Ultraviolet exposure or inflammation activates plasminogen, which stimulates melanocyte activity. Tranexamic acid inhibits plasmin activity and cuts the signal pathway from inflammation or ultraviolet exposure to melanin activation. It brightens and also improves hyperpigmentation caused by inflammation, including darkening after acne and allergic reactions.

Clinical studies report that 2% to 3% tranexamic acid used for 8 to 12 weeks produces an improvement rate of 60% to 80% for melasma. In tests on post-inflammatory hyperpigmentation, the tranexamic acid group showed better erythema index and pigmentation scores than a control group using vitamin C alone.

Three properties make it attractive for a manufacturer. It is gentle and not photosensitizing, so it suits morning and evening use. It is highly water soluble and stable, so it does not discolor. Its limits are slow single-ingredient action, needing 4 to 8 weeks, and moderate transdermal absorption that calls for penetration enhancers or a partner active.

Why Does Glabridin Cost More Than the Other Three Combined?

Glabridin costs more because the extraction yield is roughly 0.08% of the licorice root, and only high-purity material performs, so the raw material is priced by the gram rather than by the kilogram.

Glabridin is a multi-pathway botanical active. It inhibits tyrosinase, scavenges free radicals to prevent ultraviolet-induced hyperpigmentation, and adds anti-inflammatory and soothing effects. In vitro work shows that high-purity glabridin at 90% or above has a tyrosinase inhibition rate 80 times that of vitamin C and 232 times that of kojic acid. An 8-week clinical test on human volunteers using a serum with 0.1% high-purity glabridin raised subject skin brightness by 18.5% with no irritation or redness, and subjects rated the skin feel as rich and moisturizing.

The cost structure has a second layer. Purity determines the result, and low-purity extracts not only underperform but also carry lipophilic impurities that affect skin feel. Screening the raw material and running a high-end emulsification process is where the cost lands, which makes glabridin a test of the manufacturer rather than of the ingredient list.

What Does a Full Comparison of Brightening Ingredients Show?

Dimension	Niacinamide	377 (Phenylethyl Resorcinol)	Tranexamic Acid	Glabridin
Melanin pathway	Blocks melanosome transfer to keratinocytes, inhibition 35% to 68%	Inhibits tyrosinase at the source, 22 times kojic acid and 49 times arbutin	Cuts the plasmin-mediated inflammation to melanin signal	Inhibits tyrosinase plus antioxidant and anti-inflammatory action
Effective loading	2% to 5%	0.5%, the Chinese regulatory ceiling	2% to 3%, 8 to 12 week course	0.1% at high purity
Clinical result	21.4% reduction in hyperpigmentation spot area at 5% over 12 weeks	28% reduction in spot area and 14% L-value increase at 0.5% over 12 weeks	60% to 80% improvement rate for melasma over 8 to 12 weeks	18.5% brightness increase at 0.1% over 8 weeks
Formulation barrier	Low, water soluble and process tolerant	High, poor water solubility, discolors under light and heat, needs encapsulation	Low, water soluble and stable, does not discolor	Very high, purity dependent with lipophilic impurities
Irritation risk	Redness and stinging above 10%, driven by nicotinic acid impurities	Some irritation, sensitive skin needs a tolerance build	Very low, not photosensitizing	Very low, suitable for sensitive skin
Cost driver	Low raw material cost, mature supply chain	Encapsulation and antioxidant system work	Low to moderate, needs a penetration enhancer	Extraction yield near 0.08%, priced by purity
China claim route	Brightening claim possible as an ordinary cosmetic	Spot-fading claim needs special registration	Melasma and post-inflammatory hyperpigmentation support special registration	Spot-fading positioning supports special registration
Best fit	Oily and combination skin, young buyers, budget targets	Advanced brightening with clear spot-fading goals	Sensitive skin, acne marks, melasma, post-inflammatory hyperpigmentation	Prestige and clean beauty positioning with a sensory story

Which Brightening Combinations Outperform Single Actives?

Three-act combinations outperform single-ingredient positioning because they cover the pathway at more than one point without pushing any single active past its own limit.

377 with tranexamic acid covers source inhibition and the inflammation signal, which suits a spot-fading product with a redness concern. Niacinamide with glabridin covers transport blocking and multi-pathway antioxidant action, which suits a prestige daily brightening product with a lower regulatory burden. Tranexamic acid with niacinamide covers post-inflammatory hyperpigmentation and transport blocking, which suits an acne-mark product for sensitive skin.

The 2026 market trend points this way. Current formulations no longer rely on one ingredient, and full-chain synergy across source inhibition, transport blocking, and anti-inflammatory action is what produces a gentle and efficient brightening product. Knowing where each active's boundary sits is what makes a stack work rather than raise cost.

Which Brightening Ingredient Mix Fits Your Product Line?

Brand position	Recommended mix	Claim route	Testing scope
Mass market daily brightening	Niacinamide at 5% with glabridin at 0.05%	Ordinary cosmetic brightening claim	4-week in-vitro panel plus a 28-day human tolerance panel
Advanced spot fading	377 at 0.5% with tranexamic acid at 3%	Special registration for spot fading	4-week in-vitro panel plus an 8 to 12 week spot-fading panel
Acne mark and sensitive skin	Tranexamic acid at 3% with niacinamide at 3%	Special registration for the inflammation pathway	4-week in-vitro panel plus an 8-week post-inflammatory panel
Prestige clean beauty	Glabridin at 0.1% with a botanical antioxidant	Special registration for spot fading	4-week in-vitro panel plus an 8-week brightness panel
Cost-led basic brightening	Niacinamide at 4% with a botanical extract	Ordinary cosmetic brightening claim	4-week in-vitro panel plus a 28-day human tolerance panel

DEVA Skincare holds 22 special cosmetics certificates with 21 more under application, which covers the registration route a spot-fading product needs in China. The group holds more than 70 granted patents, works from 5,000 or more mature formulas, and runs 150 efficacy and safety test protocols in-house, including melanin inhibition and cell efficacy and toxicity testing alongside CAM irritation and preservative challenge. Six laboratories handle cell testing, product efficacy evaluation with VISIA imaging across 12 skin indicators, plant extraction and fermentation, active ingredient analysis with HPLC, gas chromatography and UV-Vis, packaging testing with xenon lamp aging, and heavy metal testing. Production runs 72 inspection and process control steps.

Two research institutes, two postdoctoral and technical service stations, and three centers cover application R&D, process technology, and product evaluation. A 2,000-mu herb cultivation base in Shennongjia supports the botanical side of the ingredient library, and seven high-efficacy extractables are production ready, one of which is registered as a national new cosmetic ingredient. More than 30 R&D engineers and 30 industry experts work across four manufacturing sites with a combined monthly capacity above 20 million units.

The catalogue gives a sense of what the brightening and soothing lines already produce at scale. A brightening and spot-fading series ships 3.8 million units a year and a centella soothing cream 3.7 million units. Sampling takes one week and mass production takes six weeks after sample approval, with standard MOQ at 5,000 units.

Send your brand position, target market, and intended claim through the inquiry form below, and our R&D team will map the brightening ingredient mix and the registration route for your project.

Which brightening ingredient works fastest?

377 shows results fastest among the four. A clinical test found 0.5% phenylethyl resorcinol reduced spot area by 28% and raised the skin tone L-value by 14% over 12 weeks. Tranexamic acid needs 4 to 8 weeks for visible change when used alone, and its 8 to 12 week course produces a 60% to 80% improvement rate for melasma. Niacinamide and glabridin are slower but carry lower irritation risk.

Do brightening products need special registration in China?

It depends on the claim. Products claiming spot fading and whitening fall under special cosmetics registration, which adds a longer review track and requires supporting data before submission. Niacinamide at cosmetic levels can support a brightening claim as an ordinary cosmetic without that route. Choosing the active and the claim wording together at the brief stage is what keeps the registration scope manageable.

Why does 377 change color during storage?

Phenylethyl resorcinol is highly prone to oxidizing and turning yellow or brown under light and high temperature. It also dissolves poorly in water. A stable formula needs encapsulation technology, a protective antioxidant system, and an emulsification process that avoids heat damage. This is why the same 0.5% loading can perform differently between two manufacturers.

What is the effective concentration of tranexamic acid?

Clinical studies report 2% to 3% tranexamic acid used for 8 to 12 weeks produces a 60% to 80% improvement rate for melasma. It is highly water soluble and stable, so it does not discolor, but its transdermal absorption is moderate. High-end formulations partner it with a penetration enhancer or with another brightening active such as niacinamide.

What is the MOQ and lead time for a brightening serum?

Standard MOQ is 5,000 units, with aluminum cans starting at 10,000 units and ampoules at 200,000 units. Sampling takes one week and mass production takes six weeks after sample approval. Each test protocol takes about four weeks, and a spot-fading claim adds an 8 to 12 week human panel, so a special-registration product needs a longer schedule.

Can niacinamide and tranexamic acid be combined?

Yes, and the combination is common for acne marks and sensitive skin. Tranexamic acid addresses the inflammation pathway that drives post-inflammatory hyperpigmentation, while niacinamide blocks melanosome transfer and adds barrier support and oil control. Both are water soluble and process tolerant, so the pairing carries little formulation risk and needs no special encapsulation.